{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:20:01Z","timestamp":1787556001110,"version":"build-2736575974"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 2 diabetes mellitus (T2D) is a major global health challenge associated with a high burden of cardiovascular and microvascular complications. Endothelial dysfunction is a hallmark of T2D and represents a critical link between metabolic abnormalities and vascular disease. Chronic hyperglycemia, insulin resistance, obesity-associated inflammation, oxidative stress, and mitochondrial dysfunction disrupt endothelial homeostasis, resulting in impaired nitric oxide bioavailability, vascular inflammation, endothelial senescence, barrier dysfunction, and defective vascular repair. However, the molecular mechanisms integrating metabolic stress with endothelial injury in T2D remain incompletely understood. Neddylation is a reversible ubiquitin-like post-translational modification mediated by neural precursor cell expressed, developmentally downregulated 8 (NEDD8). Through activation of Cullin-RING E3 ubiquitin ligases and modification of non-cullin substrates, neddylation regulates protein turnover, signal transduction, metabolism, inflammation, oxidative stress responses, and mitochondrial homeostasis. Emerging evidence suggests that dysregulated neddylation contributes to several metabolic abnormalities implicated in endothelial dysfunction, including insulin resistance, obesity-associated metabolic dysfunction, oxidative stress, and mitochondrial dysfunction. In diabetic retinopathy, excessive cullin neddylation promotes degradation of protective factors such as nuclear factor erythroid 2-related factor 2 (NRF2) and heterogeneous nuclear ribonucleoprotein A2\/B1 (hnRNPA2B1), thereby enhancing oxidative stress, inflammation, vascular leakage, and pathological angiogenesis. Conversely, physiological neddylation appears necessary for endothelial homeostasis through regulation of endothelial barrier integrity, angiogenesis, and stabilization of vascular endothelial growth factor receptor 2 (VEGFR2). Although direct evidence remains largely limited to retinal endothelial cells and diabetic retinopathy models, current findings support the hypothesis that dysregulated neddylation may act as an important molecular link between metabolic dysfunction and endothelial injury in diabetes. Pharmacological modulation of the neddylation pathway, including inhibition of the NEDD8-activating enzyme with MLN4924 (pevonedistat), improves metabolic homeostasis, suppresses inflammatory signaling, enhances antioxidant defenses, and attenuates vascular injury in preclinical studies. In this review, we summarize current advances in neddylation biology, discuss emerging evidence linking dysregulated neddylation to diabetes-associated endothelial dysfunction, highlight critical knowledge gaps, and evaluate the opportunities and challenges of targeting the neddylation pathway for the prevention and treatment of diabetic vascular complications.<\/jats:p>","DOI":"10.1038\/s41401-026-01910-w","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:28:06Z","timestamp":1787552886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neddylation as a molecular integrator of metabolic dysfunction and endothelial dysfunction in type 2 diabetes"],"prefix":"10.1038","author":[{"given":"Zhongjian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1161\/ATVBAHA.116.306940","volume":"36","author":"CM Boulanger","year":"2016","unstructured":"Boulanger CM. Endothelium. Arterioscler Thromb Vasc Biol. 2016;36:e26\u201331. https:\/\/doi.org\/10.1161\/ATVBAHA.116.306940.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1910_CR3","first-page":"853","volume":"3","author":"HA Hadi","year":"2007","unstructured":"Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853\u201376.","journal-title":"Vasc Health Risk Manag"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/327237a0","volume":"327","author":"HE Andrews","year":"1987","unstructured":"Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987;327:237\u20139. https:\/\/doi.org\/10.1038\/327237a0.","journal-title":"Nature"},{"key":"1910_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","volume":"130","author":"AS De Vriese","year":"2000","unstructured":"De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963\u201374. https:\/\/doi.org\/10.1038\/sj.bjp.0703393.","journal-title":"Br J Pharmacol"},{"key":"1910_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1540\/jsmr.39.249","volume":"39","author":"CR Triggle","year":"2003","unstructured":"Triggle CR, Hollenberg M, Anderson TJ, Ding H, Jiang Y, Ceroni L, et al. The endothelium in health and disease\u2013a target for therapeutic intervention. J Smooth Muscle Res. 2003;39:249\u201367. https:\/\/doi.org\/10.1540\/jsmr.39.249.","journal-title":"J Smooth Muscle Res"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/ATVBAHA.120.314346","volume":"41","author":"Y Gao","year":"2021","unstructured":"Gao Y, Galis ZS. Exploring the role of endothelial cell resilience in cardiovascular health and disease. Arterioscler Thromb Vasc Biol. 2021;41:179\u201385. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314346.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bja\/aeh163","volume":"93","author":"HF Galley","year":"2004","unstructured":"Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth. 2004;93:105\u201313. https:\/\/doi.org\/10.1093\/bja\/aeh163.","journal-title":"Br J Anaesth"},{"key":"1910_CR9","doi-asserted-by":"publisher","unstructured":"Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol. 2006:213\u201354. https:\/\/doi.org\/10.1007\/3-540-32967-6_7.","DOI":"10.1007\/3-540-32967-6_7"},{"key":"1910_CR10","doi-asserted-by":"publisher","first-page":"H985","DOI":"10.1152\/ajpheart.00292.2006","volume":"291","author":"M Feletou","year":"2006","unstructured":"Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291:H985\u20131002. https:\/\/doi.org\/10.1152\/ajpheart.00292.2006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1910_CR11","doi-asserted-by":"crossref","unstructured":"Feletou M. The endothelium: part 1: multiple functions of the endothelial cells-focus on endothelium-derived vasoactive mediators. San Rafael (CA): Morgan & Claypool Life Sciences; 2011.","DOI":"10.4199\/C00031ED1V01Y201105ISP019"},{"key":"1910_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.atv.0000051384.43104.fc","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168\u201375. https:\/\/doi.org\/10.1161\/01.atv.0000051384.43104.fc.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1910_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359255","volume":"15","author":"DR Yang","year":"2024","unstructured":"Yang DR, Wang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol. 2024;15:1359255. https:\/\/doi.org\/10.3389\/fendo.2024.1359255.","journal-title":"Front Endocrinol"},{"key":"1910_CR14","doi-asserted-by":"publisher","unstructured":"Dubsky M, Veleba J, Sojakova D, Marhefkova N, Fejfarova V, Jude EB. Endothelial dysfunction in diabetes mellitus: new insights. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms241310705.","DOI":"10.3390\/ijms241310705"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yu Q, Li Z, Zhao Y, Sun Y. Protein neddylation and its role in health and diseases. Signal Transduct Target Ther. 2024;9:85. https:\/\/doi.org\/10.1038\/s41392-024-01800-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1910_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.molcel.2018.06.002","volume":"70","author":"W Zhou","year":"2018","unstructured":"Zhou W, Xu J, Tan M, Li H, Li H, Wei W, et al. UBE2M is a stress-inducible dual E2 for neddylation and ubiquitylation that promotes targeted degradation of UBE2F. Mol Cell. 2018;70:1008\u201324 e1006. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.002.","journal-title":"Mol Cell"},{"key":"1910_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41594-019-0370-3","volume":"27","author":"AM Vogl","year":"2020","unstructured":"Vogl AM, Phu L, Becerra R, Giusti SA, Verschueren E, Hinkle TB, et al. Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020;27:210\u201320. https:\/\/doi.org\/10.1038\/s41594-019-0370-3.","journal-title":"Nat Struct Mol Biol"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s10753-025-02259-8","volume":"48","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu C, Tong J, He C, Ling X, Xiang J, et al. Inhibition of cullin3 neddylation alleviates diabetic retinopathy by activating Nrf2 signaling to combat ROS-induced oxidative stress and inflammation. Inflammation. 2025;48:3194\u2013205. https:\/\/doi.org\/10.1007\/s10753-025-02259-8.","journal-title":"Inflammation"},{"key":"1910_CR19","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.272.45.28557","volume":"272","author":"T Kamitani","year":"1997","unstructured":"Kamitani T, Kito K, Nguyen HP, Yeh ET. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 1997;272:28557\u201362. https:\/\/doi.org\/10.1074\/jbc.272.45.28557.","journal-title":"J Biol Chem"},{"key":"1910_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/embor.2008.183","volume":"9","author":"G Rabut","year":"2008","unstructured":"Rabut G, Peter M. Function and regulation of protein neddylation. \u2018Protein modifications: beyond the usual suspects\u2019 review series. EMBO Rep. 2008;9:969\u201376. https:\/\/doi.org\/10.1038\/embor.2008.183.","journal-title":"EMBO Rep"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2008.07.022","volume":"134","author":"DM Duda","year":"2008","unstructured":"Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell. 2008;134:995\u20131006. https:\/\/doi.org\/10.1016\/j.cell.2008.07.022.","journal-title":"Cell"},{"key":"1910_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/s1097-2765(03)00452-0","volume":"12","author":"H Walden","year":"2003","unstructured":"Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL Jr., et al. The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol Cell. 2003;12:1427\u201337. https:\/\/doi.org\/10.1016\/s1097-2765(03)00452-0.","journal-title":"Mol Cell"},{"key":"1910_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.molcel.2004.12.020","volume":"17","author":"DT Huang","year":"2005","unstructured":"Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA. Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8\u2019s E1. Mol Cell. 2005;17:341\u201350. https:\/\/doi.org\/10.1016\/j.molcel.2004.12.020.","journal-title":"Mol Cell"},{"key":"1910_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/onc.2015.104","volume":"35","author":"A Bailly","year":"2016","unstructured":"Bailly A, Perrin A, Bou Malhab LJ, Pion E, Larance M, Nagala M, et al. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. Oncogene. 2016;35:415\u201326. https:\/\/doi.org\/10.1038\/onc.2015.104.","journal-title":"Oncogene"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.str.2012.10.013","volume":"21","author":"JK Monda","year":"2013","unstructured":"Monda JK, Scott DC, Miller DJ, Lydeard J, King D, Harper JW, et al. Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes. Structure. 2013;21:42\u201353. https:\/\/doi.org\/10.1016\/j.str.2012.10.013.","journal-title":"Structure"},{"key":"1910_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.molcel.2009.01.011","volume":"33","author":"DT Huang","year":"2009","unstructured":"Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, Scott DC, et al. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell. 2009;33:483\u201395. https:\/\/doi.org\/10.1016\/j.molcel.2009.01.011.","journal-title":"Mol Cell"},{"key":"1910_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm3919","volume":"16","author":"RI Enchev","year":"2015","unstructured":"Enchev RI, Schulman BA, Peter M. Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 2015;16:30\u201344. https:\/\/doi.org\/10.1038\/nrm3919.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1910_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107532","volume":"210","author":"H Ren","year":"2024","unstructured":"Ren H, Luan Z, Zhang R, Zhang H, Bian C. A novel approach to explore metabolic diseases: neddylation. Pharmacol Res. 2024;210:107532. https:\/\/doi.org\/10.1016\/j.phrs.2024.107532.","journal-title":"Pharmacol Res"},{"key":"1910_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2320934121","volume":"121","author":"L Gu","year":"2024","unstructured":"Gu L, Du Y, Chen J, Hasan MN, Clayton YD, Matye DJ, et al. Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance. Proc Natl Acad Sci USA. 2024;121:e2320934121. https:\/\/doi.org\/10.1073\/pnas.2320934121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1910_CR30","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cmet.2023.07.003","volume":"35","author":"MJ Gonzalez-Rellan","year":"2023","unstructured":"Gonzalez-Rellan MJ, Fernandez U, Parracho T, Novoa E, Fondevila MF, da Silva Lima N, et al. Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism. Cell Metab. 2023;35:1630\u201345.e1635. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.003.","journal-title":"Cell Metab"},{"key":"1910_CR31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2023.05.011","volume":"35","author":"X Lu","year":"2023","unstructured":"Lu X, Kong X, Wu H, Hao J, Li S, Gu Z, et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metab. 2023;35:1390\u2013405.e1398. https:\/\/doi.org\/10.1016\/j.cmet.2023.05.011.","journal-title":"Cell Metab"},{"key":"1910_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/cdd.2016.6","volume":"23","author":"HS Park","year":"2016","unstructured":"Park HS, Ju UI, Park JW, Song JY, Shin DH, Lee KH, et al. PPARgamma neddylation essential for adipogenesis is a potential target for treating obesity. Cell Death Differ. 2016;23:1296\u2013311. https:\/\/doi.org\/10.1038\/cdd.2016.6.","journal-title":"Cell Death Differ"},{"key":"1910_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101275","volume":"53","author":"M Serrano-Macia","year":"2021","unstructured":"Serrano-Macia M, Simon J, Gonzalez-Rellan MJ, Azkargorta M, Goikoetxea-Usandizaga N, Lopitz-Otsoa F, et al. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis. Mol Metab. 2021;53:101275. https:\/\/doi.org\/10.1016\/j.molmet.2021.101275.","journal-title":"Mol Metab"},{"key":"1910_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s40200-025-01837-9","volume":"25","author":"H Li","year":"2026","unstructured":"Li H, Zeng R, Liu J, Wang H. Role of neddylation in diabetes metabolism: potential therapeutic target. J Diabetes Metab Disord. 2026;25:20. https:\/\/doi.org\/10.1007\/s40200-025-01837-9.","journal-title":"J Diabetes Metab Disord"},{"key":"1910_CR35","doi-asserted-by":"publisher","unstructured":"Chen C, Gu L, Matye DJ, Clayton YD, Hasan MN, Wang Y, et al. Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. Proc Natl Acad Sci USA. 2022;119. https:\/\/doi.org\/10.1073\/pnas.2111737119.","DOI":"10.1073\/pnas.2111737119"},{"key":"1910_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L. Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer. 2019;18:77. https:\/\/doi.org\/10.1186\/s12943-019-0979-1.","journal-title":"Mol Cancer"},{"key":"1910_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bioactmat.2023.12.025","volume":"34","author":"R Zeng","year":"2024","unstructured":"Zeng R, Lv B, Lin Z, Chu X, Xiong Y, Knoedler S, et al. Neddylation suppression by a macrophage membrane-coated nanoparticle promotes dual immunomodulatory repair of diabetic wounds. Bioact Mater. 2024;34:366\u201380. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.12.025.","journal-title":"Bioact Mater"},{"key":"1910_CR38","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458:732\u20136. https:\/\/doi.org\/10.1038\/nature07884.","journal-title":"Nature"},{"key":"1910_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","volume":"37","author":"JE Brownell","year":"2010","unstructured":"Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ, et al. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell. 2010;37:102\u201311. https:\/\/doi.org\/10.1016\/j.molcel.2009.12.024.","journal-title":"Mol Cell"},{"key":"1910_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/cas.13133","volume":"108","author":"T Sakaue","year":"2017","unstructured":"Sakaue T, Fujisaki A, Nakayama H, Maekawa M, Hiyoshi H, Kubota E, et al. Neddylated Cullin 3 is required for vascular endothelial-cadherin-mediated endothelial barrier function. Cancer Sci. 2017;108:208\u201315. https:\/\/doi.org\/10.1111\/cas.13133.","journal-title":"Cancer Sci"},{"key":"1910_CR41","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1038\/onc.2013.473","volume":"33","author":"M Tan","year":"2014","unstructured":"Tan M, Li H, Sun Y. Endothelial deletion of Sag\/Rbx2\/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis. Oncogene. 2014;33:5211\u201320. https:\/\/doi.org\/10.1038\/onc.2013.473.","journal-title":"Oncogene"},{"key":"1910_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1096\/fj.14-259663","volume":"29","author":"VF Curtis","year":"2015","unstructured":"Curtis VF, Ehrentraut SF, Campbell EL, Glover LE, Bayless A, Kelly CJ, et al. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. FASEB J. 2015;29:208\u201315. https:\/\/doi.org\/10.1096\/fj.14-259663.","journal-title":"FASEB J"},{"key":"1910_CR43","doi-asserted-by":"publisher","first-page":"dju083","DOI":"10.1093\/jnci\/dju083","volume":"106","author":"L Li","year":"2014","unstructured":"Li L, Wang M, Yu G, Chen P, Li H, Wei D, et al. Overactivated neddylation pathway as a therapeutic target in lung cancer. J Natl Cancer Inst. 2014;106:dju083. https:\/\/doi.org\/10.1093\/jnci\/dju083.","journal-title":"J Natl Cancer Inst"},{"key":"1910_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1593\/neo.11420","volume":"13","author":"L Jia","year":"2011","unstructured":"Jia L, Li H, Sun Y. Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia. 2011;13:561\u20139. https:\/\/doi.org\/10.1593\/neo.11420.","journal-title":"Neoplasia"},{"key":"1910_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.21","volume":"5","author":"WT Yao","year":"2014","unstructured":"Yao WT, Wu JF, Yu GY, Wang R, Wang K, Li LH, et al. Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Cell Death Dis. 2014;5:e1059. https:\/\/doi.org\/10.1038\/cddis.2014.21.","journal-title":"Cell Death Dis"},{"key":"1910_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08881-0","author":"Y Chang","year":"2026","unstructured":"Chang Y, Chen Q, Xu X, Lyu X, Xu L, Hu Q, et al. UBE2M-mediated neddylation modification stabilizes VEGFR2 to delay pulmonary vascular endothelial cell senescence. Cell Death Dis. 2026. https:\/\/doi.org\/10.1038\/s41419-026-08881-0.","journal-title":"Cell Death Dis"},{"key":"1910_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.67.3.5","volume":"67","author":"TR Chen","year":"2026","unstructured":"Chen TR, Zhou JX, Hou YR, Zhang YN, Li CX, Zhu J, et al. Neddylation-mediated hnRNPA2B1 degradation aggravates retinal endothelial cell dysfunction in diabetic retinopathy by regulating miR-93-5p\/VEGFA. Invest Ophthalmol Vis Sci. 2026;67:5. https:\/\/doi.org\/10.1167\/iovs.67.3.5.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1910_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2024.04.216","volume":"219","author":"Y Chen","year":"2024","unstructured":"Chen Y, Tong J, Liu C, He C, Xiang J, Yao G, et al. MSC-derived small extracellular vesicles mitigate diabetic retinopathy by stabilizing Nrf2 through miR-143-3p-mediated inhibition of neddylation. Free Radic Biol Med. 2024;219:76\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.216.","journal-title":"Free Radic Biol Med"},{"key":"1910_CR49","doi-asserted-by":"publisher","unstructured":"Zhou Q, Li H, Li Y, Tan M, Fan S, Cao C, et al. Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells. JCI Insight. 2019;4. https:\/\/doi.org\/10.1172\/jci.insight.121582","DOI":"10.1172\/jci.insight.121582"},{"key":"1910_CR50","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1073\/pnas.1910765117","volume":"117","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang YL, Qiu G, Pian L, Guo L, Cao H, et al. Hepatic neddylation targets and stabilizes electron transfer flavoproteins to facilitate fatty acid beta-oxidation. Proc Natl Acad Sci USA. 2020;117:2473\u201383. https:\/\/doi.org\/10.1073\/pnas.1910765117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1910_CR51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41417-024-00729-z","volume":"31","author":"JB Park","year":"2024","unstructured":"Park JB, Moon GH, Cho A, Kwon M, Park JW, Yi EC, et al. Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration. Cancer Gene Ther. 2024;31:599\u2013611. https:\/\/doi.org\/10.1038\/s41417-024-00729-z.","journal-title":"Cancer Gene Ther"},{"key":"1910_CR52","doi-asserted-by":"publisher","unstructured":"Ge M, Huang L, Ma Y, Sun S, Wu L, Xu W, et al. MLN4924 treatment diminishes excessive lipid storage in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) by stimulating hepatic mitochondrial fatty acid oxidation and lipid metabolites. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14112460.","DOI":"10.3390\/pharmaceutics14112460"},{"key":"1910_CR53","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ni1514","volume":"8","author":"S Menon","year":"2007","unstructured":"Menon S, Chi H, Zhang H, Deng XW, Flavell RA, Wei N. COP9 signalosome subunit 8 is essential for peripheral T cell homeostasis and antigen receptor-induced entry into the cell cycle from quiescence. Nat Immunol. 2007;8:1236\u201345. https:\/\/doi.org\/10.1038\/ni1514.","journal-title":"Nat Immunol"},{"key":"1910_CR54","doi-asserted-by":"publisher","first-page":"28892","DOI":"10.1074\/jbc.M302890200","volume":"278","author":"T Gan-Erdene","year":"2003","unstructured":"Gan-Erdene T, Nagamalleswari K, Yin L, Wu K, Pan ZQ, Wilkinson KD. Identification and characterization of DEN1, a deneddylase of the ULP family. J Biol Chem. 2003;278:28892\u2013900. https:\/\/doi.org\/10.1074\/jbc.M302890200.","journal-title":"J Biol Chem"},{"key":"1910_CR55","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1002\/cam4.1578","volume":"7","author":"J Yu","year":"2018","unstructured":"Yu J, Huang WL, Xu QG, Zhang L, Sun SH, Zhou WP, et al. Overactivated neddylation pathway in human hepatocellular carcinoma. Cancer Med. 2018;7:3363\u201372. https:\/\/doi.org\/10.1002\/cam4.1578.","journal-title":"Cancer Med"},{"key":"1910_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4049\/jimmunol.1202041","volume":"190","author":"SF Ehrentraut","year":"2013","unstructured":"Ehrentraut SF, Kominsky DJ, Glover LE, Campbell EL, Kelly CJ, Bowers BE, et al. Central role for endothelial human deneddylase-1\/SENP8 in fine-tuning the vascular inflammatory response. J Immunol. 2013;190:392\u2013400. https:\/\/doi.org\/10.4049\/jimmunol.1202041.","journal-title":"J Immunol"},{"key":"1910_CR57","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41388-020-01586-4","volume":"40","author":"H Ochiiwa","year":"2021","unstructured":"Ochiiwa H, Ailiken G, Yokoyama M, Yamagata K, Nagano H, Yoshimura C, et al. TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia. Oncogene. 2021;40:1217\u201330. https:\/\/doi.org\/10.1038\/s41388-020-01586-4.","journal-title":"Oncogene"},{"key":"1910_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-021-01070-w","volume":"14","author":"YC Zheng","year":"2021","unstructured":"Zheng YC, Guo YJ, Wang B, Wang C, Mamun MAA, Gao Y, et al. Targeting neddylation E2s: a novel therapeutic strategy in cancer. J Hematol Oncol. 2021;14:57. https:\/\/doi.org\/10.1186\/s13045-021-01070-w.","journal-title":"J Hematol Oncol"},{"key":"1910_CR59","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1158\/1535-7163.MCT-18-0644","volume":"18","author":"C Yoshimura","year":"2019","unstructured":"Yoshimura C, Muraoka H, Ochiiwa H, Tsuji S, Hashimoto A, Kazuno H, et al. TAS4464, a highly potent and selective inhibitor of NEDD8-activating enzyme, suppresses neddylation and shows antitumor activity in diverse cancer models. Mol Cancer Ther. 2019;18:1205\u201316. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0644.","journal-title":"Mol Cancer Ther"},{"key":"1910_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02658-9","volume":"42","author":"Q Hu","year":"2025","unstructured":"Hu Q, Li X, Wang P, Xie Y. Pan-cancer analysis unveils the role and mechanisms of neddylation modifications in tumorigenesis. Med Oncol. 2025;42:119. https:\/\/doi.org\/10.1007\/s12032-025-02658-9.","journal-title":"Med Oncol"},{"key":"1910_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ajhg.2022.12.003","volume":"110","author":"IJJ Muffels","year":"2023","unstructured":"Muffels IJJ, Schene IF, Rehmann H, Massink MPG, van der Wal MM, Bauder C, et al. Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegeneration. Am J Hum Genet. 2023;110:146\u201360. https:\/\/doi.org\/10.1016\/j.ajhg.2022.12.003.","journal-title":"Am J Hum Genet"},{"key":"1910_CR62","doi-asserted-by":"publisher","unstructured":"Roy B. Pathophysiological mechanisms of diabetes-induced macrovascular and microvascular complications: the role of oxidative stress. Med Sci. 2025;13:87. https:\/\/doi.org\/10.3390\/medsci13030087.","DOI":"10.3390\/medsci13030087"},{"key":"1910_CR63","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s12325-025-03185-9","volume":"42","author":"K Islam","year":"2025","unstructured":"Islam K, Islam R, Nguyen I, Malik H, Pirzadah H, Shrestha B, et al. Diabetes mellitus and associated vascular disease: pathogenesis, complications, and evolving treatments. Adv Ther. 2025;42:2659\u201378. https:\/\/doi.org\/10.1007\/s12325-025-03185-9.","journal-title":"Adv Ther"},{"key":"1910_CR64","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11239-013-1000-2","volume":"37","author":"X Zhang","year":"2014","unstructured":"Zhang X, McGeoch SC, Johnstone AM, Holtrop G, Sneddon AA, MacRury SM, et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis. 2014;37:455\u201363. https:\/\/doi.org\/10.1007\/s11239-013-1000-2.","journal-title":"J Thromb Thrombolysis"},{"key":"1910_CR65","doi-asserted-by":"publisher","unstructured":"Gallo G, Savoia C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25052973.","DOI":"10.3390\/ijms25052973"},{"key":"1910_CR66","first-page":"S54","volume":"32","author":"F Cosentino","year":"1998","unstructured":"Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol. 1998;32:S54\u201361.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1910_CR67","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527\u201332. https:\/\/doi.org\/10.1161\/01.CIR.0000091257.27563.32.","journal-title":"Circulation"},{"key":"1910_CR68","doi-asserted-by":"publisher","first-page":"H705","DOI":"10.1152\/ajpheart.00793.2024","volume":"329","author":"RA Okazaki","year":"2025","unstructured":"Okazaki RA, Rizvi SH, Lyons R, Behrooz L, Hamburg NM. Vascular dysfunction in diabetes and pharmacotherapeutic opportunities: a focus on endothelial cell health. Am J Physiol Heart Circ Physiol. 2025;329:H705\u201318. https:\/\/doi.org\/10.1152\/ajpheart.00793.2024.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1910_CR69","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.110.014506","volume":"124","author":"SM Shenouda","year":"2011","unstructured":"Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124:444\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.014506.","journal-title":"Circulation"},{"key":"1910_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019755","volume":"10","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Naga Srikanth Garikipati V, Truongcao MM, Cimini M, Huang G, Wang C, et al. Serum-derived small extracellular vesicles from diabetic mice impair angiogenic property of microvascular endothelial cells: role of EZH2. J Am Heart Assoc. 2021;10:e019755. https:\/\/doi.org\/10.1161\/JAHA.120.019755.","journal-title":"J Am Heart Assoc"},{"key":"1910_CR71","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.7150\/thno.70821","volume":"12","author":"G Huang","year":"2022","unstructured":"Huang G, Cheng Z, Hildebrand A, Wang C, Cimini M, Roy R, et al. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition. Theranostics. 2022;12:4415\u201330. https:\/\/doi.org\/10.7150\/thno.70821.","journal-title":"Theranostics"},{"key":"1910_CR72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12933-025-02825-2","volume":"24","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Truongcao MM, Mallaredy V, Cimini M, Thej C, Joladarashi D, et al. Muscle-specific miR-499-5p delivered by small extracellular vesicles impairs endothelial function and ischemic hindlimb recovery in diabetic mice. Cardiovasc Diabetol. 2025;24:273. https:\/\/doi.org\/10.1186\/s12933-025-02825-2.","journal-title":"Cardiovasc Diabetol"},{"key":"1910_CR73","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.molcel.2009.09.004","volume":"35","author":"Y Chen","year":"2009","unstructured":"Chen Y, Yang Z, Meng M, Zhao Y, Dong N, Yan H, et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell. 2009;35:841\u201355. https:\/\/doi.org\/10.1016\/j.molcel.2009.09.004.","journal-title":"Mol Cell"},{"key":"1910_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yjmcc.2015.01.019","volume":"81","author":"D Pandey","year":"2015","unstructured":"Pandey D, Hori D, Kim JH, Bergman Y, Berkowitz DE, Romer LH. NEDDylation promotes endothelial dysfunction: a role for HDAC2. J Mol Cell Cardiol. 2015;81:18\u201322. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.01.019.","journal-title":"J Mol Cell Cardiol"},{"key":"1910_CR75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1160\/TH13-02-0155","volume":"110","author":"Y Asare","year":"2013","unstructured":"Asare Y, Shagdarsuren E, Schmid JA, Tilstam PV, Grommes J, El Bounkari O, et al. Endothelial CSN5 impairs NF-kappaB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thromb Haemost. 2013;110:141\u201352. https:\/\/doi.org\/10.1160\/TH13-02-0155.","journal-title":"Thromb Haemost"},{"key":"1910_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","volume":"34","author":"S Klein","year":"2022","unstructured":"Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE. Why does obesity cause diabetes?. Cell Metab. 2022;34:11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.012.","journal-title":"Cell Metab"},{"key":"1910_CR77","doi-asserted-by":"publisher","first-page":"35756","DOI":"10.1074\/jbc.M112.397703","volume":"287","author":"FM Chang","year":"2012","unstructured":"Chang FM, Reyna SM, Granados JC, Wei SJ, Innis-Whitehouse W, Maffi SK, et al. Inhibition of neddylation represses lipopolysaccharide-induced proinflammatory cytokine production in macrophage cells. J Biol Chem. 2012;287:35756\u201367. https:\/\/doi.org\/10.1074\/jbc.M112.397703.","journal-title":"J Biol Chem"},{"key":"1910_CR78","doi-asserted-by":"publisher","DOI":"10.64898\/2026.01.28.702366","author":"L Gu","year":"2026","unstructured":"Gu L, Xiong L, Hasan MN, Du Y, Wu T, Li T. A selective Cullin 3 RING E3 ligase inhibitor attenuates hyperglycemia via dual insulin sensitizing and insulinotropic action. bioRxiv. 2026. https:\/\/doi.org\/10.64898\/2026.01.28.702366.","journal-title":"bioRxiv"},{"key":"1910_CR79","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbabio.2008.05.001","volume":"1777","author":"G Twig","year":"2008","unstructured":"Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta. 2008;1777:1092\u20137. https:\/\/doi.org\/10.1016\/j.bbabio.2008.05.001.","journal-title":"Biochim Biophys Acta"},{"key":"1910_CR80","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00204-023-03599-w","volume":"97","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhou H, Chang X. Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury. Arch Toxicol. 2023;97:3023\u201335. https:\/\/doi.org\/10.1007\/s00204-023-03599-w.","journal-title":"Arch Toxicol"},{"key":"1910_CR81","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jcp.28969","volume":"235","author":"R Qin","year":"2020","unstructured":"Qin R, Lin D, Zhang L, Xiao F, Guo L. Mst1 deletion reduces hyperglycemia-mediated vascular dysfunction via attenuating mitochondrial fission and modulating the JNK signaling pathway. J Cell Physiol. 2020;235:294\u2013303. https:\/\/doi.org\/10.1002\/jcp.28969.","journal-title":"J Cell Physiol"},{"key":"1910_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4508762","volume":"2019","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Pan Q, Wang X, Li D, Lin Y, Man F, et al. Impaired mitochondrial fusion and oxidative phosphorylation triggered by high glucose is mediated by Tom22 in endothelial cells. Oxid Med Cell Longev. 2019;2019:4508762. https:\/\/doi.org\/10.1155\/2019\/4508762.","journal-title":"Oxid Med Cell Longev"},{"key":"1910_CR83","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1080\/21655979.2022.2026552","volume":"13","author":"J Xiang","year":"2022","unstructured":"Xiang J, Zhang C, Di T, Chen L, Zhao W, Wei L, et al. Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells. Bioengineered. 2022;13:3486\u2013502. https:\/\/doi.org\/10.1080\/21655979.2022.2026552.","journal-title":"Bioengineered"},{"key":"1910_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07936-y","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Liu Y, Li Y, Li D, Mei Z, et al. Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies. Cell Death Dis. 2025;16:652. https:\/\/doi.org\/10.1038\/s41419-025-07936-y.","journal-title":"Cell Death Dis"},{"key":"1910_CR85","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ekir.2024.12.029","volume":"10","author":"Q Li","year":"2025","unstructured":"Li Q, Shang J, Inagi R. Control of mitochondrial quality: a promising target for diabetic kidney disease treatment. Kidney Int Rep. 2025;10:994\u20131010. https:\/\/doi.org\/10.1016\/j.ekir.2024.12.029.","journal-title":"Kidney Int Rep"},{"key":"1910_CR86","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","volume":"24","author":"SB Cullinan","year":"2004","unstructured":"Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol. 2004;24:8477\u201386. https:\/\/doi.org\/10.1128\/MCB.24.19.8477-8486.2004.","journal-title":"Mol Cell Biol"},{"key":"1910_CR87","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","volume":"24","author":"A Kobayashi","year":"2004","unstructured":"Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004;24:7130\u20139. https:\/\/doi.org\/10.1128\/MCB.24.16.7130-7139.2004.","journal-title":"Mol Cell Biol"},{"key":"1910_CR88","doi-asserted-by":"publisher","unstructured":"He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 2020;21:4777. https:\/\/doi.org\/10.3390\/ijms21134777.","DOI":"10.3390\/ijms21134777"},{"key":"1910_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-017-3267-7","volume":"446","author":"A Kumar","year":"2018","unstructured":"Kumar A, Shaha C. RBX1-mediated ubiquitination of SESN2 promotes cell death upon prolonged mitochondrial damage in SH-SY5Y neuroblastoma cells. Mol Cell Biochem. 2018;446:1\u20139. https:\/\/doi.org\/10.1007\/s11010-017-3267-7.","journal-title":"Mol Cell Biochem"},{"key":"1910_CR90","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","volume":"28","author":"T Yamada","year":"2018","unstructured":"Yamada T, Murata D, Adachi Y, Itoh K, Kameoka S, Igarashi A, et al. Mitochondrial stasis reveals p62-mediated ubiquitination in parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease. Cell Metab. 2018;28:588\u2013604.e585. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.014.","journal-title":"Cell Metab"},{"key":"1910_CR91","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1161\/CIRCRESAHA.124.324285","volume":"135","author":"W Wang","year":"2024","unstructured":"Wang W, Li E, Zou J, Qu C, Ayala J, Wen Y, et al. Ubiquitin ligase RBX2\/SAG regulates mitochondrial ubiquitination and mitophagy. Circ Res. 2024;135:e39\u201356. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.324285.","journal-title":"Circ Res"},{"key":"1910_CR92","doi-asserted-by":"publisher","first-page":"26448","DOI":"10.1073\/pnas.2005395117","volume":"117","author":"L Zhang","year":"2020","unstructured":"Zhang L, Jing H, Li H, Chen W, Luo B, Zhang H, et al. Neddylation is critical to cortical development by regulating Wnt\/beta-catenin signaling. Proc Natl Acad Sci USA. 2020;117:26448\u201359. https:\/\/doi.org\/10.1073\/pnas.2005395117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1910_CR93","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ajhg.2013.07.017","volume":"93","author":"PE Bonnen","year":"2013","unstructured":"Bonnen PE, Yarham JW, Besse A, Wu P, Faqeih EA, Al-Asmari AM, et al. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am J Hum Genet. 2013;93:471\u201381. https:\/\/doi.org\/10.1016\/j.ajhg.2013.07.017.","journal-title":"Am J Hum Genet"},{"key":"1910_CR94","doi-asserted-by":"publisher","unstructured":"Zou J, Wang W, Qu C, Zhang L, Zambrano-Carrasco J, Li Y, et al. Neddylation regulates mitochondrial dynamics and turnover in the adult heart. bioRxiv. 2025. https:\/\/doi.org\/10.64898\/2025.12.03.692150.","DOI":"10.64898\/2025.12.03.692150"},{"key":"1910_CR95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13578-021-00569-6","volume":"11","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zheng Y, Sun Y. Neddylation regulation of mitochondrial structure and functions. Cell Biosci. 2021;11:55. https:\/\/doi.org\/10.1186\/s13578-021-00569-6.","journal-title":"Cell Biosci"},{"key":"1910_CR96","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.redox.2016.02.008","volume":"8","author":"AC Anderica-Romero","year":"2016","unstructured":"Anderica-Romero AC, Hernandez-Damian J, Vazquez-Cervantes GI, Torres I, Gonzalez-Herrera IG, Pedraza-Chaverri J. The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation. Redox Biol. 2016;8:341\u20137. https:\/\/doi.org\/10.1016\/j.redox.2016.02.008.","journal-title":"Redox Biol"},{"key":"1910_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7283639","volume":"2019","author":"S Yu","year":"2019","unstructured":"Yu S, Xie L, Liu Z, Li C, Liang Y. MLN4924 exerts a neuroprotective effect against oxidative stress via Sirt1 in spinal cord ischemia-reperfusion injury. Oxid Med Cell Longev. 2019;2019:7283639. https:\/\/doi.org\/10.1155\/2019\/7283639.","journal-title":"Oxid Med Cell Longev"},{"key":"1910_CR98","doi-asserted-by":"publisher","unstructured":"Yu H, Luo H, Chang L, Wang S, Geng X, Kang L, et al. The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice. Proc Natl Acad Sci USA. 2022;119. https:\/\/doi.org\/10.1073\/pnas.2111896119","DOI":"10.1073\/pnas.2111896119"},{"key":"1910_CR99","doi-asserted-by":"publisher","unstructured":"Maruhashi T, Higashi Y. Pathophysiological association between diabetes mellitus and endothelial dysfunction. Antioxidants. 2021;10:1306. https:\/\/doi.org\/10.3390\/antiox10081306.","DOI":"10.3390\/antiox10081306"},{"key":"1910_CR100","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","volume":"16","author":"DJ Fu","year":"2023","unstructured":"Fu DJ, Wang T. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. J Hematol Oncol. 2023;16:87. https:\/\/doi.org\/10.1186\/s13045-023-01485-7.","journal-title":"J Hematol Oncol"},{"key":"1910_CR101","doi-asserted-by":"publisher","unstructured":"Zhou H, Su H, Chen W. Neddylation regulates class IIa and III histone deacetylases to mediate myoblast differentiation. Int J Mol Sci. 2021;22:9509. https:\/\/doi.org\/10.3390\/ijms22179509.","DOI":"10.3390\/ijms22179509"},{"key":"1910_CR102","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1182\/bloodadvances.2022007334","volume":"6","author":"L Ades","year":"2022","unstructured":"Ades L, Girshova L, Doronin VA, Diez-Campelo M, Valcarcel D, Kambhampati S, et al. Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS\/chronic myelomonocytic leukemia or low-blast-percentage AML. Blood Adv. 2022;6:5132\u201345. https:\/\/doi.org\/10.1182\/bloodadvances.2022007334.","journal-title":"Blood Adv"},{"key":"1910_CR103","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41420-020-00296-w","volume":"6","author":"J Ferris","year":"2020","unstructured":"Ferris J, Espona-Fiedler M, Hamilton C, Holohan C, Crawford N, McIntyre AJ, et al. Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer. Cell Death Discov. 2020;6:61. https:\/\/doi.org\/10.1038\/s41420-020-00296-w.","journal-title":"Cell Death Discov"},{"key":"1910_CR104","doi-asserted-by":"publisher","unstructured":"Tang H, Pang X, Li S, Tang L. The double-edged effects of MLN4924: rethinking anti-cancer drugs targeting the neddylation pathway. Biomolecules. 2024;14:738. https:\/\/doi.org\/10.3390\/biom14070738.","DOI":"10.3390\/biom14070738"},{"key":"1910_CR105","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellsig.2018.01.009","volume":"44","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang W, Sun Y, Jia L. Protein neddylation and its alterations in human cancers for targeted therapy. Cell Signal. 2018;44:92\u2013102. https:\/\/doi.org\/10.1016\/j.cellsig.2018.01.009.","journal-title":"Cell Signal"},{"key":"1910_CR106","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1158\/0008-5472.CAN-10-2062","volume":"70","author":"JJ Lin","year":"2010","unstructured":"Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res. 2010;70:10310\u201320. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2062.","journal-title":"Cancer Res"},{"key":"1910_CR107","doi-asserted-by":"publisher","first-page":"H1406","DOI":"10.1152\/ajpheart.00806.2018","volume":"316","author":"J Zou","year":"2019","unstructured":"Zou J, Ma W, Littlejohn R, Li J, Stansfield BK, Kim IM, et al. Transient inhibition of neddylation at neonatal stage evokes reversible cardiomyopathy and predisposes the heart to isoproterenol-induced heart failure. Am J Physiol Heart Circ Physiol. 2019;316:H1406\u201316. https:\/\/doi.org\/10.1152\/ajpheart.00806.2018.","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01910-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:28:07Z","timestamp":1787552887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":107,"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01910-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}